Randomized Trial Comparing Esomeprazole and Rabeprazole in First-line Eradication Therapy for Helicobacter pylori Infection based on the Serum Levels of Pepsinogens

OBJECTIVE: CYP2C19 metabolic activity influences the efficacy of Helicobacter pylori eradication therapies comprising PPIs. Rabeprazole (RPZ) and esomeprazole (EPZ) are PPIs not extensively metabolized by CYP2C19. The aim of this study was to elucidate whether or not first-line triple therapies usin...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Intern Med
Main Authors: Shimoyama, Tadashi, Chinda, Daisuke, Sawada, Yoshihiko, Komai, Kazuo, Chiba, Hironobu, Saito, Yoshiharu, Sasaki, Yoshio, Matsuzaka, Masashi, Fukuda, Shinsaku
Format: Artigo
Sprog:Inglês
Udgivet: The Japanese Society of Internal Medicine 2017
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5519461/
https://ncbi.nlm.nih.gov/pubmed/28674348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.56.7823
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker